SCHEMBL7536291

SCHEMBL7536291

Cc1cc(CSC(C)C(C(=O)NO)N(C)S(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)no1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 1/20 0.51
MMP9 P14780 12/20 0.44
MMP1 P03956 10/20 0.44
MMP13 P45452 9/20 0.44
ADAM17 P78536 6/20 0.44
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MMP2 P08253 9/20 0.41
MMP3 P08254 6/20 0.41
MMP8 P22894 6/20 0.41
MMP14 P50281 6/20 0.41
MMP16 P51512 3/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.38
GAA P10253 1/20 0.38
MMP7 P09237 2/20 0.37
ABCB11 O95342 1/20 0.37
MMP10 P09238 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536288 1.00 BMP1 (0.51) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7536737 0.92 BMP1 (0.51) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7536735 0.92 BMP1 (0.51) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7538115 0.92 BMP1 (0.51) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7538113 0.92 BMP1 (0.51) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7533839 0.84 BMP1 (0.49) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7533835 0.84 BMP1 (0.49) BMP1MMP9MMP1MMP13ADAM17
SCHEMBL7539821 0.83 MMP1 (0.46) MMP9MMP1MMP13ADAM17KMT2A
SCHEMBL7539814 0.83 MMP1 (0.46) MMP9MMP1MMP13ADAM17KMT2A
SCHEMBL7533819 0.80 MMP9 (0.44) BMP1MMP9MMP1MMP13ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed